{
  "trial_id": "NCT00787722",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age between 16-65",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "Established diagnosis of Devic's disease",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "NMO-IgG aquaporin-4 autoantibody positive",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Paraplegia or quadriplegia and legal blindness",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Any illness that in the opinion of the investigators would jeopardize the ability of the patient to tolerate aggressive chemotherapy",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Prior history of malignancy except localized basal cell, squamous skin cancer or carcinoma in situ of the cervix",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "The patient has a confirmed diagnosis of Paget's Disease of Bone and will be started on Bisphosphonate as first-line therapy.",
  "_meta": {
    "topic_id": "40",
    "trial_id": "NCT00787722",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}